Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Net Margin (2017 - 2025)

Assembly Biosciences (ASMB) has 8 years of Net Margin data on record, last reported at 85.23% in Q3 2025.

  • For Q3 2025, Net Margin rose 5520.0% year-over-year to 85.23%; the TTM value through Sep 2025 reached 103.65%, up 4041.0%, while the annual FY2024 figure was 140.87%, 71391.0% up from the prior year.
  • Net Margin reached 85.23% in Q3 2025 per ASMB's latest filing, up from 105.94% in the prior quarter.
  • Across five years, Net Margin topped out at 85.23% in Q3 2025 and bottomed at 300.66% in Q3 2021.
  • Average Net Margin over 4 years is 145.22%, with a median of 140.44% recorded in 2024.
  • Peak YoY movement for Net Margin: crashed -29098bps in 2021, then soared 6329bps in 2025.
  • A 4-year view of Net Margin shows it stood at 300.66% in 2021, then skyrocketed by 49bps to 153.04% in 2023, then rose by 8bps to 140.48% in 2024, then soared by 39bps to 85.23% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 85.23% in Q3 2025, 105.94% in Q2 2025, and 93.62% in Q1 2025.